Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Iris Neovascularization”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT00841373
What this trial is testing

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

Who this might be right for
Retinal Ischemia
Southern New England Retina Associates 1
Early research (Phase 1)Study completedNCT01069341
What this trial is testing

Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery

Who this might be right for
Rubeosis IridisProliferative Diabetic Retinopathy
Bhagat, Neelakshi, M.D., M.P.H. 4
Post-approval studies (Phase 4)Study completedNCT00557232
What this trial is testing

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Who this might be right for
GlaucomaRubeosis Iridis
Instituto de Olhos de Goiania 25
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableUnknownNCT03631108
What this trial is testing

Feasibility Study and Preliminary Application Study on Iris OCTA

Who this might be right for
ConjunctivitisGlaucomaMyopia+4 more
Shanghai Eye Disease Prevention and Treatment Center 4,000
Testing effectiveness (Phase 2)Ended earlyNCT00211471
What this trial is testing

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Who this might be right for
Severe Diabetic RetinopathyCentral Retinal Vein OcclusionChronic Inflammation+1 more
Manhattan Eye, Ear & Throat Hospital
Early research (Phase 1)Study completedNCT00295828
What this trial is testing

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Who this might be right for
Iris NeovascularizationDiabetic Retinopathy
Hermann Eye Center 10
Large-scale testing (Phase 3)Study completedNCT02641457
What this trial is testing

Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis

Who this might be right for
GlaucomaRubeosis Iridis
Instituto de Olhos de Goiania 2
Not applicableNot Yet RecruitingNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274